Ammonium Lactate 12% Drug Ingredient Requiring FDA Approval – Petition
This article was originally published in The Tan Sheet
Executive Summary
Two recent ANDA approvals for products containing ammonium lactate 12% reflect FDA's position that the skin care ingredient is a drug, Paddock Labs says in a Sept. 5 citizen petition
You may also be interested in...
Ammonium Lactate 12% Products Cosmetic, Not Subject To Rx Regs – Upsher
Hydrating and moisturizing claims for products containing ammonium lactate 12% are cosmetic claims and do not create drug status for the products, Upsher-Smith Labs asserts
Niacin Supplement For High Cholesterol Targeted In Warning Letter
Upsher-Smith Labs' Slo-Niacin was cited by FDA in a recent warning letter for claims it has made to treat hypercholesterolemia
Upsher Smith Amlactin 12% ammonium lactate cream is unapproved new drug -- FDA.
AMLACTIN 12% AMMONIUM LACTATE MARKETED APPROPRIATELY AS COSMETIC, Upsher Smith Labs maintains in response to a recent warn-ing letter from FDA declaring the topical lotion and cream to be unapproved new drugs. The Minneapolis-based company conveyed its position to the agency in an Aug. 24 letter. Following a review of Amlactin labeling and promotional materials, FDA informed Upsher Smith in an Aug. 5 letter it believes the products are intended for the "cure, mitigation, treatment or prevention of disease" or "to affect the structure or any function of the body." However, the firm does not plan to modify its product formulations and maintains its marketing claims are appropriate for a cosmetic moisturizer.